Solventum is a healthcare innovation company with approximately $8.3 billion in annual sales and over 10,000 employees worldwide. Established as an independent company through spin-off from 3M on April 1, 2024, the organisation draws on more than 70 years of healthcare experience and operates across medical devices, oral care, health information systems, and purification technologies.
The company develops solutions spanning advanced wound care, surgical technologies, intravenous site management, sterilization assurance, and patient monitoring systems. Its dental and orthodontic portfolio serves oral care markets, whilst its health information systems leverage clinical intelligence and data science to support healthcare delivery. Solventum's purification and filtration technologies serve biopharmaceutical manufacturing, industrial manufacturing, and water treatment applications.
Research and development activity spans health, material science, and data science domains. The organisation positions itself at the intersection of these technical fields to address challenges faced by healthcare professionals and improve patient outcomes across the continuum of care.
